By identifying the types of molecules that accumulate inside P. aeruginosa, researchers drew a roadmap for new antibiotic development for combatting these deadly pathogens.
Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.